Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :28117336
Publication Date : //

CD5 molecule-like and transthyretin as putative biomarkers of chronic myeloid leukemia - an insight from the proteomic analysis of human plasma.


Better and sensitive biomarkers are needed to help understand the mechanism of disease onset, progression, prognosis and monitoring of the therapeutic response. Aim of this study was to identify the candidate circulating markers of chronic-phase chronic myeloid leukemia (CP-CML) manifestations, having potential to develop into predictive- or monitoring-biomarkers. A proteomic approach, two-dimensional gel electrophoresis in conjunction with mass spectrometry (2DE-MS), was employed for this purpose. Based on the spot intensity measurements, six proteins were found to be consistently dysregulated in CP-CML subjects compared to the healthy controls [false discovery rate (FDR) threshold ≤0.05]. These were identified as α-1-antichymotrypsin, α-1-antitrypsin, CD5 molecule-like, stress-induced phosphoprotein 1, vitamin D binding protein isoform 1 and transthyretin by MS analysis [PMF score ≥79; data accessible via ProteomeXchange with identifier PXD002757]. Quantitative ELISA, used for validation of candidate proteins both in the pre-treated and nilotinib-treated CP-CML cases, demonstrate that CD5 molecule-like, transthyretin and alpha-1-antitrypsin may serve as useful predictive markers and aid in monitoring the response of TKI-based therapy (ANOVA p < 0.0001). Two of the circulating marker proteins, identified in this study, had not previously been associated with chronic- or acute-phase myeloid leukemia. Exploration of their probable association with CP-CML, in a larger study cohort, may add to our understanding of the disease mechanism besides developing clinically useful biomarkers in future.

Authors : Fatima Iram , Sadaf Saima , Musharraf Syed Ghulam , Hashmi Naghma , Akhtar Muhammad Waheed ,

Related products :

Catalog number Product name Quantity
T18-022-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-023-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-022-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-021-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-022-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-023-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-021-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-022-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-021-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-023-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-023-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-021-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) 0.1 mg
T18-021-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) tissue 0.1 mg
T18-022-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) tissue 0.1 mg
T18-023-T1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Myeloid Leukemia) tissue 0.1 mg
BYA9643-1 CD13, Aminopeptidase N, Chronic Myeloid Leukemia, 150kD, Clone WM_47, Mab anti_Human vial
G5250 Putative chronic lymphocytic leukemia up-regulated protein 1 opposite strand transcript protein (CLLU1OS), Human, ELISA Kit 96T
CSB-EL005563HU Human Putative chronic lymphocytic leukemia up-regulated protein 1 opposite strand transcript protein(CLLU1OS) ELISA kit 96T
EIAAB08011 CLLU1OS,Homo sapiens,Human,Putative chronic lymphocytic leukemia up-regulated protein 1 opposite strand transcript protein
CSB-EL005563HU Human Putative chronic lymphocytic leukemia up-regulated protein 1 opposite strand transcript protein(CLLU1OS) ELISA kit SpeciesHuman 96T
CLU1O_HUMAN ELISA Kit FOR Putative chronic lymphocytic leukemia up-regulated protein 1 opposite strand transcript protein; organism: Human; gene name: CLLU1OS 96T
EIAAB43851 B-cell chronic lymphocytic leukemia tumor suppressor Leu5,E3 ubiquitin-protein ligase TRIM13,Homo sapiens,Human,LEU5,Leukemia-associated protein 5,Putative tumor suppressor RFP2,Ret finger protein 2,R
T18-009-N1 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-009-N2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg
T18-011-T2 Matched Tumor_ Normal Human Leukemia, bone marrow Tissue Lysates (Chronic Lymphocytic Leukemia) 0.1 mg


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur